Influenza – Frontline Management and Prevention
WV Program Preassessment

Question Title

* 1. How confident are you in your ability to evaluate clinical symptoms, risk factors for complications from influenza, diagnostic tests, and prevalence of influenza in the community to recommend antiviral treatment strategies?

Very confident

Confident

Moderately confident

Slightly confident

Not confident

Very confident

Confident

Moderately confident

Slightly confident

Not confident

Question Title

* 2. Using a scale where 5=always and 1=never, rate how often you CURRENTLY educate elderly patients on the cardiovascular impact of influenza to increase vaccination uptake.

5=always

4=very often

3=sometimes

2=rarely

1=never

5=always

4=very often

3=sometimes

2=rarely

1=never

Question Title

* 3. Which statement about baloxavir marboxil is CORRECT?

The oral suspension of baloxavir had a longer time to reduction of viral shedding when compared to oseltamivir in children

People exposed to influenza through a household contact treated with baloxavir were just as likely to develop influenza as those treated with placebo

In patients 12 years and older at high risk of influenza complications with influenza B infection, baloxavir was associated with a significantly shorter time to improvement of influenza symptoms (TTIIS) when compared to placebo and oseltamivir

Baloxavir-treated patients with infections caused by resistant I38X virus have TTIIS longer than that of placebo

Not sure

Question Title

* 4. Which statement on antiviral treatment of influenza is CORRECT?

The Centers for Disease Control (CDC) recommends that clinicians should wait for the results of influenza diagnostic tests before making decisions about initiating antiviral tratment

Oseltamivir is associated with a 1-day reduction in symptoms if started within 48 hours of symptom onset

Rimantadine and amantadine are effective against influenza A and B viruses

The Infectious Diseases Society of America (IDSA) guidelines recommend against treatment of symptomatic outpatients who are household contacts of persons at high risk of complications from influenza

Not sure

Question Title

* 5. Albert is a 72-year-old man with well-controlled hypertension who is otherwise healthy seeing you for his annual visit in September. He lives in a single-family home. When you ask if he’s received the seasonal influenza vaccine, he tells you he got sick several years ago after getting the influenza vaccine and hasn’t gotten it since then. You are aware he has a fear of needles. What would be the most appropriate strategy for Albert?

Give Albert the live, attenuated intranasal vaccine to avoid having to give him an injection

Recommend that Albert reconsider getting the vaccine, and allow him to go home to think about what you have discussed

Exempt Albert from the vaccine due to his fear of needles and generally good health status

Educate Albert about his high risk of experiencing influenza-related complications due to his age and recommend he get the vaccine today

Not sure

Question Title

* 6. Joan is a 36-year-old woman presenting to your office with a 3-day history of fever, malaise, and nonproductive cough. Her symptoms have gotten worse over the past 24 hours, and the cough has required her to increase use of her short-acting bronchodilator for her asthma. She lives with her husband, a 13-year-old son, and her 70-year-old mother. Her husband and son are otherwise healthy, and her mother has a medical history of diabetes and epilepsy. No one in the household has received the annual influenza vaccine. It is early January, and influenza is circulating in the community according to recent epidemiological reports.

Please select all of the following items that are CURRENTLY consistent with your clinical approach for this patient (select all that apply):

Send Joan home with the following treatment plan: manage her symptoms with over-the-counter medication and supportive care, and tell her to return if she doesn’t feel better in 2 days

Prescribe an empiric antibiotic and antiviral therapy

Have Joan do a rapid influenza diagnostic test before making a decision about therapy

Have Joan do a rapid strep test before making a decision about therapy

Prescribe empiric oseltamivir treatment for Joan

Prescribe empiric baloxavir treatment for Joan

Prescribe zanamivir treatment for Joan

Recommend that Joan’s family members receive the influenza vaccine and that she should as well after her illness resolves

Prescribe antiviral prophylaxis for Joan’s husband, son, and mother

Influenza – Frontline Management and Prevention WV Program Preassessment

Question Title

* 1. How confident are you in your ability to evaluate clinical symptoms, risk factors for complications from influenza, diagnostic tests, and prevalence of influenza in the community to recommend antiviral treatment strategies?

Question Title

* 2. Using a scale where 5=always and 1=never, rate how often you CURRENTLY educate elderly patients on the cardiovascular impact of influenza to increase vaccination uptake.

Question Title

* 3. Which statement about baloxavir marboxil is CORRECT?

Question Title

* 4. Which statement on antiviral treatment of influenza is CORRECT?

Question Title

Question Title

Influenza – Frontline Management and Prevention
WV Program Preassessment